PeptiDream Inc. (PPTDF)

Market Cap	1.31B -25.6%
Revenue (ttm)	121.15M -62.5%
Net Income	-39.35M
EPS	-0.30
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	471
Open	10.42
Previous Close	10.42
Day's Range	10.42 - 10.42
52-Week Range	9.61 - 13.75
Beta	0.07
RSI	42.68
Earnings Date	Feb 16, 2026

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 756
• Stock Exchange: OTCMKTS
• Ticker Symbol: PPTDF

Financial Performance

In 2024, PeptiDream's revenue was 46.68 billion, an increase of 62.57% compared to the previous year's 28.71 billion. Earnings were 15.01 billion, an increase of 394.70%.

Financial numbers in JPY